Login to Your Account



Entereg’s Positive Phase III Data Drive Up Adolor’s Stock

By Aaron Lorenzo


Thursday, February 9, 2006
Adolor Corp. unveiled positive Phase III data on Entereg (alvimopan), its partnered product for postoperative ileus, boosting shares in the company. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription